CCR5 and autoimmune disease: CCR5-expressing CTLs have been associated with severe autoimmune diseases (Mackay, 2014), and CCR5 ligands are abundant in the upper respiratory tract during acute hyperinflammation associated with viral infection (Chua et al., 2020); silencing homotypic recruitment may well prove beneficial in such contexts.